» Research
Cell Therapeutics Note: This Week’s News, Pixantrone Competition and Market Analysis
June 13, 2009 at 9:56 pm EST |
3 Comments |
Research Update: BioMarin Reports Phase 1 PEG-PAL Data
June 9, 2009 at 10:03 am EST |
Add A Comment |
What’s Hot in May – Facet Biotech, Genasense’s Last Stand, PEG-PAL, Etc…
May 20, 2009 at 8:40 pm EST |
1 Comment |
Facet Biotech: Daclizumab for Multiple Sclerosis, Hype or Truth?
May 14, 2009 at 10:39 am EST |
Add A Comment |
Acorda’s Fampridine: NDA Accepted, Priority Review, Hype or Truth?
May 6, 2009 at 12:34 pm EST |
1 Comment |
More Cell Therapeutics: OPAXIO vs. Pixantrone, The Race is On
May 2, 2009 at 7:05 pm EST |
8 Comments |



